What steps can we take to increase patient participation in clinical trials, particularly among diverse populations?

Gary Puckrein, President and CEO of the National Minority Quality Forum, discusses the importance of diversity in clinical trials at the launch of the new I’m In campaign to increase the number of minority participants in clinical trials.

 

 

One of the great challenges that we face right now is to get greater diversity in clinical trials, because we don’t know what works and who it might work in. It’s important that we get the full diversity of the American population in trials so that medicines are safe and efficacious. – Read More